News

Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.
Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...
There are molecular testing gaps in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) treatment, highlighting ...
Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...
Air pollution exposure, both before and after birth, significantly escalates the risk of respiratory infections in children.
Long-term exposure to water contaminants, even below the regulatory limits, significantly increases the risk of chronic ...
Prenatal and early-life factors significantly influence childhood obesity trajectories, highlighting the need for early ...
New research reveals critical gaps in treatment for advanced non–small cell lung cancer (NSCLC), emphasizing the need for ...
Racial disparities in childhood obesity have risen due to social determinants, food insecurity, and systemic barriers, ...
The recent decision in Kennedy v Braidwood could give Robert F. Kennedy Jr, secretary of HHS, the ability to remove all members of the US Preventive Services Task Force (USPSTF) if desired ...
During the “Tech Innovations in Community Oncology” meeting from Tennessee Oncology, oncologists explore artificial ...
Panelists highlight that despite established guidelines, delays and gaps in molecular profiling—especially for KMT2A rearrangements—persist due to report complexity, misinterpretation, and ...